Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeuti BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE ...
Pyxis Lamda SPP / S. Korea MR2 50,145 2017 Spot n/a n/a Pyxis Theta (2) SPP / S. Korea MR2 51,795 2013 Time $ 22,000 Dec 2025 Pyxis Karteria (3) Hyundai / S. Korea MR2 46,652 2013 Time 24,500 Sep ...
The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of ...
Built for professional use, the Blackmagic Pyxis takes the proven HDR full-frame sensor from the Blackmagic Cinema Camera 6K and puts it in a box-style camera that can be configured to suit ...
Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical ...
Maroussi, Greece – January 30, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback